Cargando…
Overexpression of GINS4 is associated with poor prognosis and survival in glioma patients
BACKGROUND: GINS4, an indispensable component of the GINS complex, is vital for a variety of cancer. However, no known empirical research has focused on exploring relationships between GINS4 and glioma. Thus, this study aims to understand and explain the role of GINS4 in glioma. METHOD: First, we us...
Autores principales: | Liu, Binfeng, Liu, Zhendong, Wang, Yanbiao, Lian, Xiaoyu, Han, Zhibin, Cheng, Xingbo, Zhu, Yongjie, Liu, Runze, Zhao, Yaoye, Gao, Yanzheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8461916/ https://www.ncbi.nlm.nih.gov/pubmed/34556022 http://dx.doi.org/10.1186/s10020-021-00378-0 |
Ejemplares similares
-
GNG12 as A Novel Molecular Marker for the Diagnosis and Treatment of Glioma
por: Liu, Runze, et al.
Publicado: (2022) -
Overexpressed XRCC2 as an independent risk factor for poor prognosis in glioma patients
por: Liu, Zhendong, et al.
Publicado: (2021) -
ITGB3BP is a potential biomarker associated with poor prognosis of glioma
por: Liu, Zhendong, et al.
Publicado: (2021) -
Role of RHOC in evaluating an adverse prognosis in patients with glioma and its potential prognostic value
por: Zhang, Bo, et al.
Publicado: (2021) -
DRAXIN as a Novel Diagnostic Marker to Predict the Poor Prognosis of Glioma Patients
por: Jia, Yulong, et al.
Publicado: (2022)